Condition
Bradyarrhythmias
Total Trials
5
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
P 4 (1)
Trial Status
Unknown3
Enrolling By Invitation1
Recruiting1
Clinical Trials (5)
Showing 5 of 5 trials
NCT06656468Enrolling By InvitationPrimary
Outcome of Patients Undergoing Leadless Pacemaker Implantaton
NCT04931550RecruitingPrimary
Clinical Study of Impact of Different Pacing Site in Patients
NCT04919447UnknownPrimary
Clinical Study of LBBP
NCT01717495UnknownPrimary
Thromboembolic Complications After Pacemaker or Implantable Cardioverter-Defibrillator Procedures
NCT01717469Phase 4UnknownPrimary
Safety and the Effects of Isolated Left Ventricular Pacing in Patients With Bradyarrhythmias
Showing all 5 trials